Verified Nov 2026
Electronics & Software
·
Palo Alto, California
·
Since 2010
Glooko is a digital health company headquartered in Palo Alto, California, founded in 2010 and reporting an estimated 200-500 employees and an estimated $10-50M revenue band. The company is privately held and sells a SaaS platform and mobile app for diabetes management used by patients and clinicians. Its offerings serve the healthcare sector across more than 30 countries. In May 2026 it received FDA 510(k) clearance for its EndoTool IV Cloud product, a hospital glucose management system.
Glooko at a glance
Revenue
$10-50M
Est. band
Employees
200-500
Founded
2010
Headquarters
Palo Alto, California
Certifications
ISO 13485
Import activity
4
Industries
Automotive
Electric Vehicles
Medical
Consumer Goods
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
4
Named foreign suppliers
3
Top origins
China
Shared foreign counterparties do not establish that these companies buy from Glooko.
What this tells a buyer
The record contains no customs or trade data, and the most recent reported development is the launch of the Glooko EndoTool IV Cloud on 2 November 2026, following its 510(k) clearance in May 2026.
The company holds ISO 13485 certification and offers software-based diabetes management tools, with a connected care platform that integrates with more than 200 diabetes and health monitoring devices.
Glooko is privately held, reports serving more than 8,000 clinical locations, and expanded its diabetes data management partnership with mylife Diabetes Care in May 2026.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & active
16 years in operation (founded 2010).
Holds ISO 13485 certification(s) per public sources.
Overview
Glooko is a digital health company headquartered in Palo Alto, California, founded in 2010 and reporting an estimated 200-500 employees and an estimated $10-50M revenue band. The company is privately held and sells a SaaS platform and mobile app for diabetes management used by patients and clinicians. Its offerings serve the healthcare sector across more than 30 countries. In May 2026 it received FDA 510(k) clearance for its EndoTool IV Cloud product, a hospital glucose management system.
At a glance
Attribute | Detail |
|---|---|
Founded | 2010 |
Headquarters | Palo Alto, California |
Employees | 200-500 |
Revenue | $10-50M (estimated) |
Primary capability | Electronics & Software |
Certifications | ISO 13485 |
What Glooko makes
The company holds ISO 13485 certification and offers software-based diabetes management tools, with a connected care platform that integrates with more than 200 diabetes and health monitoring devices.
Products and capabilities described on the company's own site include Sensor (source: glooko.com).
Certifications
Glooko is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — glooko.com
Trade and customs footprint
The record contains no customs or trade data, and the most recent reported development is the launch of the Glooko EndoTool IV Cloud on 2 November 2026, following its 510(k) clearance in May 2026. US customs bill-of-lading records list 4 inbound shipments across 3 foreign suppliers, with top origins including China.
Latest developments
2026-11-02 — Glooko Launches Glooko EndoTool IV Cloud, Advancing Patient-Specific Glycemic Management for Hospitals - Glooko (glooko.com)
2026-09-01 — Glooko Expands Ambulatory Diabetes Management Offerings with GestationalCare™ Module for Diabetes in Pregnancy - Glooko (glooko.com)
2026-05-14 — Glooko Announces FDA 510(k) Clearance for EndoTool IV Cloud | Glooko (glooko.com)
2026-05-12 — Glooko and mylife Diabetes Care Expand Diabetes Data Management Partnership | Glooko (glooko.com)
2026-03-10 — Glooko to Expand EMEA CGM Connectivity with Roche Accu-Chek® SmartGuide Integration - Glooko (glooko.com)
2025-12-23 — 2025 Milestones and 2026 Diabetes Innovation | Glooko (glooko.com)
Company details
Glooko is privately held, reports serving more than 8,000 clinical locations, and expanded its diabetes data management partnership with mylife Diabetes Care in May 2026. Glooko was founded in 2010, has an estimated 200-500 employees, and is headquartered in Palo Alto, California. On the LightSource stability read it is rated "Established & active": 16 years in operation (founded 2010). Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Glooko make?
Glooko is a digital health company headquartered in Palo Alto, California, founded in 2010 and reporting an estimated 200-500 employees and an estimated $10-50M revenue band. The company is privately held and sells a SaaS platform and mobile app for diabetes management used by patients and clinicians. Its offerings serve the healthcare sector across more than 30 countries. In May 2026 it received FDA 510(k) clearance for its EndoTool IV Cloud product, a hospital glucose management system.
Where is Glooko headquartered?
Glooko is headquartered in Palo Alto, California (579 University Ave, Palo Alto, California, 94301-1911).
When was Glooko founded?
Glooko was founded in 2010.
How big is Glooko?
Glooko has an estimated 200-500 employees, with revenue in the $10-50M range (estimated).
What certifications does Glooko hold?
Glooko lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Does Glooko import from overseas suppliers?
US customs bill-of-lading records show 4 inbound shipments for Glooko, with top origins including China.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.